维普中文期刊产品整合服务
61篇 您的检索式:作者名="Beger G"
    题名 作者 年代 出处 被引量
1Severe acute pancreatitis: Clinical course and management显示文摘Severe acute pancreatitis (SAP) develops in about 25% of patients with acute pancreatitis (AP). Severity of AP is linked to the presence of systemic organ dysfunctions and/or necrotizing pancreatitis pathomorphologically. Risk factors determining independently the outcome of SAP are early multi-organ failure, infection of necrosis and extended necrosis (> 50%). Up to one third of patients with necrotizing pancreatitis develop in the late course infection of necroses. Morbidity of SAP is biphasic, in the first week strongly related to early and persistence of organ or multi-organ dysfunction. Clinical sepsis caused by infected necrosis leading to multi-organ failure syndrome (MOFS) occurs in the later course after the first week. To predict sepsis, MOFS or deaths in the first 48-72 h, the highest predictive accuracy has been objectified for procalcitonin and IL-8; the Sepsis- Related Organ Failure Assessment (SOFA)-score predicts the outcome in the first 48 h, and provides a daily assessment of treatment response with a high positive predictive value. Contrast-enhanced CT provides the highest diagnostic accuracy for necrotizing pancreatitis when performed after the first week of disease. Patients who suffer early organ dysfunctions or at risk of developing a severe disease require early intensive care treatment. Early vigorous intravenous fluid replacement is of foremost importance. The goal is to decrease the hematocrit or restore normal cardiocirculatory functions. Antibiotic prophylaxis has not been shown as an effective preventive treatment. Early enteral feeding is based on a high level of evidence, resulting in a reduction of local and systemic infection. Patients suffering infected necrosis causing clinical sepsis, pancreatic abscess or surgical acute abdomen are candidates for early intervention. Hospital mortality of SAP after interventional or surgical debridement has decreased in high volume centers to below 20%.Hans G Beger Bettina M Rau 2007World Journal of Gastroenterology2007,13,38:122
2Common bile duct stenosis in complicated chronic pancreatitis 显示文摘Schlosser W Siech M Beger G 2001Scand J Gastroenterol2001,36,2:1
3Biliary and gastric bypass or stenting in nonresectable periampullary cancer: analysis on the basis of controlled trials 显示文摘Schwarz A Beger H G 2000Int J Pancreatol2000,27,1:1
4The Economics of Small Business Finance:the Role of Private Equity and Debt Market in the Financial Growth Cycle显示文摘Beger A N Udell G F 1998Journal of Ranking and Finance1998,,22:1
5Gallbladder carcinoma and surgical treatment显示文摘Korth H Beger G 2000Langgenbeck''s Arch Surg2000,385,:1
6Frequency and time course of pancreatis and extrapancreatic bacterial infection in experimental acute pancreatitis in rats显示文摘Schwarz M Thomsen J Meyer H Buchler M W Beger H G 2000Surgery2000,127,:1
7Isolation of an anaerobic intestinal bacterium capable of cleaving the C-ring of isoflavonoid daidzein显示文摘Hut H G Beger R D Heinze T M 2002Arch Micro- biology2002,178,:1
8Combined PET/CT imaging: first clinical experience at University of Essen 显示文摘Frendenry LS Antock G Beger A 2003Hosp Radiol2003,3,1:1
9Prevention of sever change in acute:prediction and prevention显示文摘Beger H G Rau B Isenmann R 2001J Hepatobiliary Pancreat Surg2001,8,:1
10Natural course of acute pancreatitis显示文摘BEGER H G RAU B MAYER J 1997World J Surg1997,21,2:1
11A randomized double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis显示文摘BUCHLER M W MALFERTHEINER P BEGER H G 1999Gut1999,45,:1
12Combined PET/CT Imaging:First clinical experience at University of Essen显示文摘Frendenry LS Antock G Beger A 2003Hospital Radiology2003,3,1:1
13ComParison of jogging, the relaxation respon, and group interaction for stress reduction显示文摘Beger B G Friedmann E Eaton M 1988Joumal of Exercise Psyehology1988,,10:1
14Natural course of acute pancreatitis 显示文摘Beger H G Rau B Mayer J 1997World J Surg1997,21,2:1
15Early seizures following intracerebral hemorrhage : implications for therapy显示文摘Beger AR Liprln RB Jantos G 1998Neurology1998,38,:1
16Roleofoctreotide in the treatmento fpancreatic cancer显示文摘Ebert M Friess H Beger H G 1995Digestion1995,55,1:1
17Isolation of human intes- tinal bacteria metabolizing the natural isoflavone glycosides daid- zin and genistin 显示文摘Hur H G Lay J 0 Jr Beger R D 2000Arch Microbiol2000,174,6:1
18Natural history of necrotizing pancreatitis显示文摘BEGER H G RAU B ISENMANN R 2003Pancreatology2003,3,2:1
19Isolation of an anaero- bic intestinal bacterium capable of cleaving the C-ring of the isoflavonoid daidzein 显示文摘Hur H G Beger R D Heinze T M 2002Arch Microbiol2002,178,1:1
20Copyright law in the European Union,with special reference to Germany显示文摘BEGER G 2006Library Review2006,54,2:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费